(PharmaNewsWire.Com, January 22, 2018 ) According to Publisher, the Global Plasma Fractionation Market is accounted for $18.14 billion in 2016 and is expected to reach $30.14 billion by 2023 growing at a CAGR of 7.5% during the forecast period. Factors such as rising geriatric population and increasing number of hemophilic patients are boosting the market growth. On the contrary, strict government rules, huge cost and limited reimbursements are some of the factors hampering the market. Rising digit of hemophilic patients is creating growth opportunities for vendors in the market.
By product, immunoglobulin segment witnessed the largest market share during the forecast period. However, protease inhibitors segment is expected to witness the fastest growth rate in the next five years. The growth of this segment is mainly attributed to its increasing use for respiratory diseases and growing application in various diseases.
By region, North America accounted for largest market share followed by Europe due to increasing use of immunoglobulins in neurological diseases and increasing use of prophylaxis treatments for diagnosed patients, and the rising number of registered hemophilic patients in this region.
Some of the key players in global plasma fractionation market include Octapharma AG, Chinese Biological Products, Inc., Bio Products Laboratory, Baxter International, Inc., Csl, Ltd., Grifols International SA, Shanghai Raas Blood Products Co., Ltd, China Biologic Products, Inc., Biotest, Kedrion S.P.A., LFB SA and Sanquin.
Products Covered: -Protease Inhibitors -Coagulation Factor Concentrates -Immunoglobulin -Fractionation Process -Albumin -Other Plasma Products
End Users Covered: -Clinical Research Laboratories -Academic Institutes -Hospitals and Clinics
Regions Covered: -North America -US -Canada -Mexico -Europe -Germany -France -Italy -UK -Spain -Rest of Europe -Asia Pacific -Japan -China -India -Australia -New Zealand -Rest of Asia Pacific -South America -Argentina -Brazil -Chile -Rest of South America -Middle East & Africa -Saudi Arabia -UAE -Qatar -South Africa -Rest of Middle East & Africa
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
